Human IL-13 production is negatively influenced by CD3 engagement: Enhancement of IL-13 production by cyclosporin A

Journal of Immunology

Volumn 156, Issue 5, 1996, Pages 1818-1823

  Van Der Pouw Kraan, Tineke C T M ^a,c   Boeije, Leonie C M ^a   Troon, Josette T M ^a   Rutschmann, Susan K ^a   Wijdenes, John ^b   Aarden, Lucien A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Diaclone   (France)

^c CENTRAL LABORATORY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CYCLOSPORIN A; INTERLEUKIN 13; INTERLEUKIN 4; T LYMPHOCYTE RECEPTOR;

ARTICLE; CELLULAR DISTRIBUTION; HUMAN; HUMAN CELL; IMMUNOREGULATION; MEMORY CELL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS REGULATION; T LYMPHOCYTE ACTIVATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD28; ANTIGENS, CD3; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYCLOSPORINE; DOWN-REGULATION; HUMANS; INTERLEUKIN-13; MICE; MICE, INBRED BALB C; RECEPTOR-CD3 COMPLEX, ANTIGEN, T-CELL;

EID: 0030024033     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Mosmann, T. R., and R. L. Coffman. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 7:145.
2. Minty, A., P. Chalon, J -M. Derocq, X. Dumont, J.-C. Guillemot, M. Kaghad, C Labit, P Leplatois, P Liauzun, B. Miloux, C. Minty, P. Casellas, G. Loison, J. Lupker, D. Shire, P. Ferrara, and D. Caput. 1993. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 362: 248.
3. McKenzie, A N. J., J A. Culpepper, R. De Waal Malefyt, F. Brière, J. Punnonen, G Aversa, A. Sato, W Dang, B. G. Cocks, S. Menon, J E. De Vries, J. Banchereau, and G. Zurawski 1993. Interleukin 1993, a T-cell-derived cytokine that regulates human monocyte and B-cell function Proc Natl Acad. Sci USA 90:3735.
4. McKenzie, A. N. J., X. Li, D A. Largaespada, A. Sato, A Kaneda, S M. Zurawski, E. L. Doyle, A Milatovich, U. Francke, N G. Copeland, N. A. Jenkins, and G. Zurawski. 1993 Structural comparison and chromosomal localization of the human and mouse IL-13 genes. J. Immunol. 150.5436.
5. De Waal Malefyt, R., C. G. Figdor, R. Huijbens, S. Mohan-Peterson, B Bennett. J Culpepper, W. Dang, G. Zurawski, and J. E De Vries. 1993. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes J. Immunol. 151:6370
6. Defrance, T., P Carayon, G. Billian, J. Guillemot, A. Minty, D. Caput, and P Ferrara. 1994. Interleukin 13 is a B cell stimulating factor. J. Exp Med 179 735.
7. Punnonen, J. G. Aversa, B. G. Cocks, A. N. J. McKenzie, S. Menon, G Zurawski, R. De Waal Malefijt, and J. E. De Vries 1993 Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci USA 90 3730.
8. Zurawski, S. M., F. Vega, Jr., B. Huyghe, and G. Zurawski. 1993. Receptor for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J. 12:2663.
9. Zurawski, S M., P Chomarat, O Djossou, C. Bidaud, A N J McKenzie. P. Miossec, J. Banchereau, and G. Zurawski. 1995. The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin 13 receptor. J. Biol. Chem. 270:13869.
10. Jinquan, T., B Deleuran, B. Gesser, H. Maare, M. Deleuran, C. G Larsen, and K. Thestrup-Pedersen. 1995. Regulation of human T lymphocyte chemotaxis in vitro by T cell-derived cytokines IL-2, IFN-γ, IL-4, IL-10, and IL-13 J. Immunol. 154:3742
11. Zurawski, G., and J. E De Vries 1994 Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol. Today 15-19.
12. Burd, P R., W. C Thompson, E E Max, and F C. Mills. 1995. Activated mast cells produce interleukin 13. J. Exp. Med. 181:1373.
13. Fior, R., N. Vita, M. Raphael, A Minty, M. C. Maillot, M C. Crevon, D. Caput, P. Biberfeld, P. Ferrara, P. Galanaud, and D. Emilie 1994. Interleukin-13 gene expression by malignant and EBV-transformed human B lymphocytes. Eur. Cytokine Netw. 5:593.
14. - Th0, Th1, and Th2 T cell clones and EBV-transformed B cells. Int Immunol. 7:1405.
15. Van Lier, R. A W , J H A Boot, A J Verhoeven, E. R. De Groot, M. Brouwer, and L. A. Aarden. 1987. Functional studies with anti-CD3 heavy chain isotype switch-variant monoclonal antibodies, accessory cell-independent induction of interleukin 2 responsiveness in T cells by ε-anti-CD3. J. Immunol. 139:2873.
16. Van der Pouw Kraan, T , I Rensink, and L. Aarden. 1993 Characterization of monoclonal antibodies to human IL-4: application in an IL-4 ELISA and differential inhibition of IL-4 bioactivity on B cells and T cells. Eur Cytokine Netw. 4:343.
17. Van der Pouw Kraan, T , C Van Kooten, H. J. A M Rensink, and L. A Aarden 1992. IL-4 production by human T cells: differential regulation of IL-4 versus IL-2 production. Eur. J. Immunol 22.1237.
18. Pfeiffer, C., J. Stein, S Southwood, H. Ketelaar, A. Sette, and K Bottomly 1995. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J Exp Med. 181: 1569.
19. Evavold, B. D., and P M. Allen. 1991. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand Science 252:1308
20. June, C. H., J. A Ledbetter, M. M. Gillespie, T. Lindsten, and C. B. Thompson. 1987 T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol. Cell Biol 7.4472.
21. Bloemena, E , M. H. J. Van Oers, S. Weinreich, A. P. Stilma-Meinesz, P. Th. A. Schellekens, and R. A W. Van Lier. 1989. The influence of cyclosporin A on the alternative pathways of human T cell activation in vitro. Eur. J. Immunol. 19:943
22. Lewis, D. B , K. S. Prickett, A. Larsen, K Grabstein, M. Weaver, and C. B. Wilson. 1988. Restricted production of interleukin 4 by activated human T cells. Proc. Natl. Acad. Sci USA 85:9743.
23. O'Keefe, S. J., and E. A. O'Neill. 1994. Cyclosporine and FK-506. immunosuppression, inhibition of transcription and the role of calcincurin. Perspect Drug Discov. Des. 2:85.
24. Rao, A. 1994. NF-ATp: a transcription factor required for the coordinate induction of several cytokine genes. Immunol Today 15.274.
25. Mouzaki, A , and D. Rungger. 1994. Properties of transcription factors regulating interleukin-2 gene transcription through the NF-AT binding site in untreated or drug-treated naive and memory T-helper cells. Blood 84:2612.
26. Li, B , P. K Sehajpal, A Khanna, H. Vlassara, A. Cerami, K. H. Stenzel, and M. Suthanthiran. 1991. Differential regulation of transforming growth factor β and interleukin 2 genes in human T cells demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reaction. J. Exp. Med. 174:1259.
27. Reem, G. H., L. A. Cook, and J. Vilcek 1983. γ Interferon synthesis by human thymocytes and T lymphocytes inhibited by cyclosporin A. Science 221:63.
28. Andersson, J., S. Nagy, C. G. Groth, and U. Andersson. 1992. Effects of FK-506 and cyclosporin A on cytokine production studied in vitro at a single-cell level. Immunology 75:136.
29. Costello, R., C. Mawas, and D. Olive. 1993. Differential immuno-suppressive effects of metabolic inhibitors on T-lymphocyte activation. Eur. Cytokine Netw 4.139.
30. Chen, S. S., G. Stancscu, A. E. Magalski, and Y. Y. Qian. 1989. Cyclosporin A is an adjuvant in murine IgE antibody responses J. Immunol. 142:4225.
31. Wang, J. M., M. Denis, M. Fournier, and M. Laviolette 1993. Cyclosporin A increases the pulmonary eosinophilia induced by inhaled Aspergillus antigen in mice. Clin. Exp. Immunol. 93:323.
32. Bochner, B. S., D. A Klunk, S. A. Sterbinsky, R L. Coffman, and R. P. Schleimer. 1995. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J. Immunol. 154:799.
33. Bundick, R. V., R I. Craggs, and E. Holness. 1995. The effect of cyclosporin A, FK506, and rapamycin on the marine chronic graft-versus-host response, an in vivo model of Th2-like activity. Clin. Exp. Immunol. 99:467.
34. Hsieh, C. S , S. E. Macatonia, C. S. Tripp, S. F. Wolf, A. O'Carra, and K. M. Murphy. 1993. Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
35. Trinchieri, G. 1994. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes Blood 84:4008.
36. Von der Weid, T, M Kopf, G. Köhler, and J. Langhome. 1994. The immune response to Plasmodium chaubaudi malaria in interleukin-4-deficient mice. Eur. J. Immunol. 24:2285.
37. Chen, S A., Q. Li, E Pearlman, and W. Chen 1995. Dual mechanism of potentation of murine antigen-specific IgE production by cyclosporin A in vitro. J. Immunol. 149:762.
38. Allen, R D , T. A. Staley, and C L. Sidman. 1993. Differential cytokine expression in acute and chronic murine graft-versus-host disease. Eur. J. Immunol. 23:333.
39. Storb, R., H. J Deeg, V. Farewell, K. Doney, F. Appelbaum, P Beatty, W. Bensinger, C. D Buckner, R. Clift, J. Hansen, R. Hill, G. Longton, L. Lum, P. Martin, R. McGuffin, J. Sanders, J. Singer, P. Stewart, K. Sullivan, R. Witherspoon, and E. D. Thomas. 1986 Marrow transplantation for severe aplastic anemia: metrotrexate alone compared with a combination of metrotrexate and cyclosporine for prevention of acute graft-versus-host disease. Blood 68:119.
40. Gorczynski, R M., and D. Wojcik. 1994. A role for nonspecific (cyclosporin A) or specific (monoclonal antibodies to ICAM-1, LFA-1, and IL-10) immunomodulation in the prolongation of skin allografts after antigen-specific pretransplant immunization or transfusion. J. Immunol. 152:2011.
41. Cash, E., A Minty, P. Ferrara, D. Caput, D. Fradelizi, and O. Rott. 1994. Macrophage-inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats J Immunol 153.4258.
42. Shevach, E. M. 1985. The effects of cyclosporin A on the immune system Annu. Rev Immunol 3:397